Introduction
============

Colon cancer is becoming a killer and seriously threatens people's health, and the incidence of colon cancer in People's Republic of China has increased significantly in recent years. Compared to that of the European countries and America, the early-onset age of colon cancer in People's Republic of China obviously has become younger, and the early diagnosis rate is also low. Early colon cancer onset is hidden, often without obvious clinical symptoms, but the illness develops slowly; most of the patients begin to see a doctor after realizing the symptoms such as purulent blood, and abdominal pain, emaciation, and anemia develop after they began to see a doctor. At that time, the disease would have developed to medium-late stage. The current clinical treatment mainly includes chemotherapy, surgery, and targeted therapy, but its function is limited, and 5-year survival rate is low, although it is well known and enshrined in modern guidelines for the treatment of the colorectal cancer that surgery is the first and primary method proven in resectable cancer, especially in clinical stage III. The occurrence and development of colon cancer are related to many genes, multiple stages, and mutual interaction of multiple factors. The current study found that the occurrence of colon cancer was related to genetics, lifestyle, environmental pollution, and many other factors. Colonic adenoma is considered as precancerous lesions of colon cancer. Most of the colon cancer develops through hyperplasia, adenoma, and canceration process. Early detection and removal of the colonic adenoma could reduce the incidence of colon cancer. Piwi proteins are tumor stem cell factors. Piwil1 and Piwil2 belong to Piwi protein family. The current research suggested that cancer stem cells were the origin of the tumor, and determined the occurrence, development, and recurrence of the tumor. The study mainly researched on abnormal expressions of Piwil1 and Piwil2 in colonic tumor and colon cancer, and explored their function in the occurrence and development of colon cancer, in order to provide certain theoretical basis for clinical treatment.

Materials and methods
=====================

Materials
---------

This study selected the colon cancer cases from July 2010 to July 2012, in the pathology department of the First Affiliated Hospital of Zhengzhou University. There were a total of 178 cases of colon adenoma specimens, which were removed under electronic colonoscopy (excluding local canceration and inflammatory polyp) and were archived as wax blocked. In 92 cases of colon cancer specimens, there were 51 cases of male, and 41 cases of female, aging 34--79, with a median age of 56.5 years. The study applied 17th edition of TNM staging system from the American Joint Committee on Cancer, published in 2010. The cases were divided as follows: 16 cases for stage I, 33 cases for stage II, 31 cases for stage III, and 12 cases for stage IV. According to the degree of differentiation, there were 31 cases of high differentiation, 39 cases of moderate (medium) differentiation, and 22 cases of low differentiation. There were 40 cases with lymph node metastasis, 52 cases with no lymph node metastasis, and 41 cases with colon adenoma and atypical hyperplasia. In the control group, there were 45 cases and above from the tissue adjacent to carcinoma with a distance above 5 cm. All the patients were with complete data, without records of having tumor in other area, and had not received radiotherapy, chemotherapy, and immunotherapy before tumor surgery or endoscopic treatment.

Reagents
--------

Piwil1 and Piwil2 rabbit antihuman polyclonal antibodies were bought from Saierbio, LLC, Tianjin, People's Republic of China. The ready-to-use ldpe-g-nvp test kits (biotin) and diaminobezidin (DAB) chromogenic agent were bought from Beijing Zhongshan Golden Bridge Biotechnology Co, Ltd, Beijing City, People's Republic of China.

Methods
-------

Specimens were fixed with 10% formaldehyde, and were conventional paraffin embedded, made into 4 μm thick serial sections, regularly dewaxed, and repaired of high temperature and high pressure. Specific steps were carried out in strict accordance with the kit instructions. Piwil1 and Piwil2 were resistant to the concentration of DAB chromogenic agent and wood grain in the ratio of 1:100 after dyeing. Phosphate-buffered saline was treated as the positive control.

Inclusion criteria
------------------

With reference to the literature, Piwi1 and Piwil2 proteins were mainly expressed in cytoplasm and nuclei. Positive expression is confirmed by yellow color or tan. The positive expression is observed using an optical microscope under a magnification of ×400; five horizons were randomly selected from each section, and each view had a count of 100 cells. According to the score-staining intensity, points were assigned as follows: 0 point for colorless, 1 point for light yellow, 2 points for tan, 3 points for brown. According to the positive cell percentage of scoring, 0 point was assigned for positive cells less than 5%, 1 point for positive cells between 5% and 24%, 2 points for positive cells between 25% and 49%, 3 points for positive cells between 50% and 74%, and 4 points for positive cells being 75% or higher. The level of expression was decided by the staining intensity score with positive cells percentage: 0--1 point for negative (−), 2--3 points for weakly positive (+), 4--5 points for positive (++), and 6--7 points for strong positive (+++). Immunohistochemical staining was performed by two highly qualified pathologists under double-blind conditions.

Statistical methods
-------------------

Data SPSS17.0 package was adopted to improve the analysis, and comparisons between the test groups were performed using *χ*^2^ analysis. The study of correlation between Piwil1 and Piwil2 proteins adopted the Spearman correlation analysis, with inspection level at *a*=0.05.

Results
=======

1.  There was positive expression of Piwil1 and Piwil2 proteins in cancer, colonic adenoma, and colonic carcinoma tissue ([Figures 1](#f1-ott-8-1259){ref-type="fig"}[](#f2-ott-8-1259){ref-type="fig"}[](#f3-ott-8-1259){ref-type="fig"}[](#f4-ott-8-1259){ref-type="fig"}[](#f5-ott-8-1259){ref-type="fig"}[6](#f6-ott-8-1259){ref-type="fig"}). Piwil1 protein in cancerous tissue compared to tissue adjacent to carcinoma: *χ*^2^=59.488, *P*=0.000; comparison between the cancer and adenoma tissue: *χ*^2^=10.126, *P*=0.001; adenoma tissue compared with tissue adjacent to carcinoma: *χ*^2^=18.031, *P*=0.000. In cancerous tissue, the results were as follows: Piwil2 protein compared to tissue adjacent to carcinoma: *χ*^2^=66.528, *P*=0.000; comparison between the cancer and adenoma tissue: *χ*^2^=7.164, *P*=0.007; adenoma tissue compared with tissue adjacent to carcinoma: *χ*^2^=22.477, *P*=0.000 ([Table 1](#t1-ott-8-1259){ref-type="table"}).

2.  For the relationship between positive expression of Piwil1 and Piwil2 proteins and clinicopathological factors of colon cancer, see [Table 2](#t2-ott-8-1259){ref-type="table"}.

3.  There were 71 cases of positive expression of Piwil1 and Piwil2 in colorectal tissues, four cases were negative, and both the expressions were significantly positively correlated (*r*=0.262, *χ*^2^=6.798, *P*\<0.05).

Discussion
==========

In recent years, the study found that in a wide variety of tumor tissues, only a small part of the tumor cells were capable of self-renewal and proliferation differentiation, which are named as tumor stem cells, and most of the cancer cells do not have this ability. Cancer stem cells occupied a very small proportion of cancer cells in tumor tissue, and could only form new tumors, while other tumor cells died after a limited proliferation differentiation.[@b1-ott-8-1259] Cancer malignant degrees were decided by the proportion of cancer stem cells in tumor tissue; the higher the ratio, the greater the malignant degree.[@b2-ott-8-1259] Mutations in tumor stem cells were derived from normal stem cells. Cancer stem cells and normal stem cells were with similar features in many ways; both had the ability of self-renewal, proliferation, and differentiation into a new tissue. Cancer stem cells played an important role in tumor occurrence, invasion, metastasis, and recurrence.[@b3-ott-8-1259] Many cancer stem cells had been isolated from leukemia, breast cancer, brain tumors, and other cancers.

Piwi form was first found by Lin in reproductive cells of fruit flies in the late 1990s, who supposed that it functioned importantly in reproduction and stem cell self-renewal.[@b4-ott-8-1259] Piwi family included Piwil1 (Hiwi), Piwil2 (his), Piwil3, and Piwil4. Piwi family had two conservative domains,[@b5-ott-8-1259] which were PAZ (Piwi/Argonaute/Zwille) structural domains and Piwi structural domains. Piwi structural domains were composed of 300 amino acids. Piwi family was an important part of microRNAs of RNA-induced silencing complex (RISC). RISC played a key role in two pathways: RNA interference and miRNA inhibition of gene expression. Piwi family had proved to be necessary for sperm formation in mice. Recent studies had confirmed that Piwi family played an important role in stem cell self-renewal, regulation, and control of spermatogenesis and translation, and was the key regulator of stem cells. Decreasing of Piwi protein expression could significantly decrease the rate of stem cell differentiation; excessive expression could increase the quantity of stem cells and rate of differentiation. The lack of human Piwi led to the failure of reproductive stem cells, and decline of embryonic development of Piwi will affect the original germ cell differentiation. Cancer stem cells had the similar characteristics of normal stem cells, with the ability of proliferation, self-renewal, and differentiation, and Piwi functioned importantly in maintenance of cancer stem cell differentiation.

Piwil1 had been firstly detected in the human testicles, through fluorescence in situ hybridization. People had found its long arm located on chromosome 12, which is also the position of adult testicular germ cell cancer-related gene. Piwil1 protein had high expression in seminoma, and no expression in testicular germ cell tumors and non-seminoma. Piwil1 was also expressed in human hematopoietic stem cells, and was not expressed in differentiated cells. In the study of Liu et al[@b6-ott-8-1259] it was found that Piwil1 protein expression in gastric cancer tissue was significantly higher than normal gastric mucosa. They[@b7-ott-8-1259] thought that Piwil1 expression in esophageal squamous carcinoma was associated with poor prognosis. In this experiment, Piwil1 in colonic tumor and colon cancer tissues were highly expressed. From the adjacent tissue, carcinoma, and colonic adenoma to colon cancer, expressions were increasing, and comparison between each and the difference were statistically significant. Expression in colon cancer tissue and correlation of tissue differentiation, TNM stages, and lymph node metastasis were statistically significant, and with gland tumor malignant progression, colon cancer malignant degree, the progression in clinical stage, and lymph node metastasis, Piwil1 protein expressions were correspondingly increasing. This indicated Piwil1 expression in precancerous lesions of colon cancer; adenoma phase has begun to work. The proliferation, invasion, and metastasis of colon cancer might have an effect to a certain degree.

In case of Piwil2 expression in mice primitive germ cells, its shortage could make spermatocyte unable to form sperm cells.[@b8-ott-8-1259] Piwil2 was located at 1p, which was usually missed in primitive neuroectodermal tumors, Wilms tumor, and many malignant tumors,[@b9-ott-8-1259] suggesting that it may play an important role in the formation of tumors. This study preliminarily applied immunohistochemical experiments to confirm that Piwil2 widely expressed in colon cancer and precancerous lesions of adenoma tissue. From the adjacent tissue, carcinoma, and adenoma to colon cancer, positive expression rate of Piwil2 protein was in the increasing trend. And comparison between the groups has statistical significance. Piwil2 protein expression in the colon, tissue differentiation, TNM stages, and lymph node metastasis has no statistical significance. This was similar with research on other tumors, and preliminarily confirmed that Piwil2 may play a role in the process of colon cancer development in its early stages, but its specific mechanism was not fully clear, and required further research with a large sample at the cellular level and molecular level.

Piwil1 and Piwil2 protein expression rose in colonic tumor stage, and in colon cancer tissue, Piwil1 and Piwil2 protein expressions were positively correlated, indicating that both proteins may have correlation in the occurrence and development of colon cancer. Piwi-interacting RNA (piRNA) was recently found as a new type of short control RNA in mice spermatogonium. Piwi family proteins mainly functioned through piRNA. From this study, Lee et al[@b10-ott-8-1259] found that through activating endogenous RNAi mechanism, Piwil2 effected on important cell signaling pathways such as Stat3/Bcl-XL and Stat3/CyclinD1, inhibited cell apoptosis, regulated cell cycle, and performed an important role in the tumorigenesis and development. Pillai et al[@b11-ott-8-1259] found that Piwil2 might have functioned through combination with target mRNA inhibition of protein synthesis.

At present, most of scholars believe that approximately 80% of colorectal cancers are developed from adenoma.[@b12-ott-8-1259] In this experiment, high expression of Piwil1 and Piwil2 had appeared in lesions in the early stages of the colon cancer (adenoma stage), which promotes that their high expression might be an early event of colon cancer.

Nowadays, people could not fully understand the function and regulatory mechanism of Piwi, and its participation in the specific mechanism of tumorigenesis, exact role in the occurrence and development of tumor, and different stages of tumor and the different expressions of different tumors are not entirely clear. While deepening on Piwi and cancer stem cells, the research could also provide a new way to study the origin, biological behavior of tumor, and the treatment against tumor. The target of the treatment of tumor is to remove the cancer cells from the body. The traditional treatment was with surgery, radiation, and chemotherapy and immunotherapy. These methods could only kill mature differentiated cancer cells, and reduce tumor size and number to a certain extent, but they could not kill the tumor stem cells, and cannot give a radical cure effect. Deepening the research on cancer stem cells may have a far-reaching influence on the idea of cancer treatment. Conventional radiation and chemotherapy cannot kill tumor stem cells, and tumor stem cells were more likely to become drug resistant, and not sensitive to radiation therapy. Therefore, treatment against tumor should focus on the purpose of killing cancer stem cells. Only in this way, one can solve the problem of tumor drug resistance, and prevent tumor metastasis. Tumor stem cell theory could change the method of chemotherapy drugs application. It was promising to invent a treatment strategy to kill cancer stem cells. Therefore, the discovery of selective killing of cancer stem cells was our research direction. Tumor treatment completion from palliative to radical change needed more in-depth understanding of the tumor.

It has been proposed that Piwil1 and Piwil2 might be potential biomarkers of colon cancers in human beings.[@b13-ott-8-1259] Furthermore, Piwil2 is widely recognized as a stem cell protein, and it is expressed in various tumors, especially colon cancers, by a mechanism of preventing apoptosis by the Stat3/Bcl-XL pathway. Therefore, Piwil1 and Piwil2 may play roles in colorectal cancer through the activation of the Stat3/Bcl-XL signaling pathway, which remains to be investigated. In addition, additional experiments are necessary to go beyond the preliminary results shown in order to provide more mechanistic insight into the functional role of Piwil1 and Piwil2 in colon cancer by small interfering RNA and overexpression techniques.

If expression is observed in cancer-adjacent mucosa to some extent, field carcinogenesis could have occurred in colorectal carcinogenesis, which is not generally observed in the sporadic colorectal carcinogenesis. If the expression of Piwil1 is related to the tumor stage, differentiation, and lymph node metastasis, Piwil1 should be related to the prognosis of the colorectal cancer. It is important to investigate the expression levels of different types of precancerous lesions with various malignant potential hyperplastic tubular, villous, and tubulo-villous polyps in future.
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###### 

Positive expression of Piwil1 and Piwil2 proteins in cancer, colonic adenoma, and cancerous tissue

  Tissue                         Number of cases   Piwil1-positive cases (%)   Piwil2-positive cases (%)
  ------------------------------ ----------------- --------------------------- ---------------------------
  Tissue adjacent to carcinoma   45                5 (11.1)                    11 (24.4)
  Colonic adenoma                41                22 (53.7)                   31 (75.6)
  Cancerous tissue               92                74 (80.4)                   85 (92.4)

###### 

Relationship between positive expression of Piwil1 and Piwil2 proteins in colon cancer tissue and its clinicopathological factors

  Clinical pathological factors   Number of cases   Number of Piwil1-positive cases (%)   *χ*^2^   *P*     Number of Piwil2-positive cases (%)   *χ*^2^   *P*
  ------------------------------- ----------------- ------------------------------------- -------- ------- ------------------------------------- -------- -------
  Sex                                                                                     1.094    0.296                                         0.240    0.624
   Male                           51                43 (84.3)                                              46 (90.2)                                      
   Female                         41                31 (75.6)                                              39 (95.1)                                      
  Age (years)                                                                             0.112    0.737                                         1.487    0.223
   55 or below                    39                32 (82.1)                                              34 (87.2)                                      
   Above 55                       53                42 (79.2)                                              51 (96.2)                                      
  AJCC 7th edition                                                                        5.403    0.020                                         1.950    0.163
  TNM stage                                                                                                                                               
   I + II stage                   49                35 (71.4)                                              43 (91.8)                                      
   III + IV stage                 43                39 (90.7)                                              42 (93.0)                                      
  Degree of differentiation                                                               10.889   0.001                                         0.014    0.906
   High                           31                19 (61.3)                                              28 (90.3)                                      
   Medium or low                  61                55 (90.2)                                              57 (93.4)                                      
  Lymph node metastasis                                                                   6.546    0.011                                         0.186    0.666
   No                             52                37 (71.2)                                              47 (90.4)                                      
   Yes                            40                37 (92.5)                                              38 (95.0)                                      

**Abbreviation:** AJCC, American Joint Committee on Cancer; TNM, tumour node metastasis.
